This thesis evaluates current therapeutic approaches to urinary tract infections, emphasizing optimized dosing and stewardship to combat multidrug-resistant pathogens. It distinguishes between infection types while addressing management needs for special populations. The work focuses on mitigating resistance through strategies like managing augmented renal clearance and the mutant selection window. Ultimately, it provides a vital framework for advancing antimicrobial stewardship in the face of rising resistance.